---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-034235"
form_type: "8-K"
ticker: null
cik: "0001873324"
company_name: "PepperLime Health Acquisition Corp"
filed_at: "2024-03-14T23:59:59+00:00"
generated_at: "2026-06-04T21:46:43.735381+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# PepperLime Health SPAC to delist March 21; ceases operations, trust disbursement March 22

## Summary
- Nasdaq notice for audit committee non-compliance after Michelle Fang's board resignation in Jan 2024.
- Company decided to cease all operations except winding up; last trading day March 21, 2024.
- Public shareholders to receive trust disbursements on or about March 22, 2024.
- Company has no plan to regain compliance with Nasdaq Listing Rule 5605.

## SEC filing metadata
- accession: 0001104659-24-034235
- form_type: 8-K
- cik: 0001873324
- company_name: PepperLime Health Acquisition Corp
- filed_at: 2024-03-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873324/000110465924034235/0001104659-24-034235-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873324/000110465924034235/tm248756d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-034235
- JSON: https://secwatch.observer/filing/0001104659-24-034235.json
- Plain text: https://secwatch.observer/filing/0001104659-24-034235.txt

## Key facts
- Listing & Compliance Notices
  PepperLime Health Acquisition Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: audit committee
  - Rules: 5605
  source text: March 11, 2024, PepperLime Health Acquisition Corporation (the “Company”) received a notice (the “Nasdaq Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), stating that as a result of Ms. Michelle Fang’s resignation from the Company’s board of directors in January 2024, the Company no longer complies with Nasdaq’s audit committee requirement as set forth in Nasdaq Listing Rule 5605, including the requirement that there are at least three independent directors on the Company’s audit committee. The Company is provided a cure period until the earlier of the Company’s next annual shareholders’
  evidence_url: https://www.sec.gov/Archives/edgar/data/1873324/000110465924034235/0001104659-24-034235-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.